avrg: GSE58827: Dynamics of the Mouse Liver
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Myod1 | mm10_v2_chr7_+_46376467_46376480 | 0.67 | 8.7e-06 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr8_+_23139064 Show fit | 30.79 |
ENSMUST00000033947.8
|
ankyrin 1, erythroid |
|
chr8_+_23139030 Show fit | 28.96 |
ENSMUST00000121075.1
|
ankyrin 1, erythroid |
|
chr11_+_58640394 Show fit | 16.64 |
ENSMUST00000075084.4
|
tripartite motif-containing 58 |
|
chr12_+_109459843 Show fit | 11.48 |
ENSMUST00000173812.1
|
delta-like 1 homolog (Drosophila) |
|
chr8_+_23139157 Show fit | 10.66 |
ENSMUST00000174435.1
|
ankyrin 1, erythroid |
|
chr1_-_132390301 Show fit | 10.56 |
ENSMUST00000132435.1
|
transmembrane and coiled-coil domains 2 |
|
chr2_-_170406501 Show fit | 10.48 |
ENSMUST00000154650.1
|
breast carcinoma amplified sequence 1 |
|
chr7_+_142441808 Show fit | 10.29 |
ENSMUST00000105971.1
ENSMUST00000145287.1 |
troponin I, skeletal, fast 2 |
|
chr12_-_76709997 Show fit | 10.19 |
ENSMUST00000166101.1
|
spectrin beta, erythrocytic |
|
chr17_+_36869567 Show fit | 10.02 |
ENSMUST00000060524.9
|
tripartite motif-containing 10 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.9 | 81.5 | GO:0006779 | porphyrin-containing compound biosynthetic process(GO:0006779) |
0.6 | 29.7 | GO:0003009 | skeletal muscle contraction(GO:0003009) |
0.8 | 16.8 | GO:0030213 | hyaluronan biosynthetic process(GO:0030213) |
2.6 | 13.2 | GO:0070103 | negative regulation of calcidiol 1-monooxygenase activity(GO:0010956) regulation of interleukin-6-mediated signaling pathway(GO:0070103) |
0.1 | 12.8 | GO:0042100 | B cell proliferation(GO:0042100) |
1.0 | 12.3 | GO:0097067 | cellular response to thyroid hormone stimulus(GO:0097067) |
1.3 | 12.1 | GO:0032264 | IMP salvage(GO:0032264) |
2.2 | 11.2 | GO:0072138 | mesenchymal cell proliferation involved in ureteric bud development(GO:0072138) |
0.4 | 10.5 | GO:0046852 | positive regulation of bone resorption(GO:0045780) positive regulation of bone remodeling(GO:0046852) |
0.1 | 9.6 | GO:0006936 | muscle contraction(GO:0006936) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.5 | 79.6 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
0.5 | 29.6 | GO:0031672 | A band(GO:0031672) |
1.4 | 25.1 | GO:0005861 | troponin complex(GO:0005861) |
0.2 | 21.6 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.1 | 19.2 | GO:0014069 | postsynaptic density(GO:0014069) |
0.2 | 13.8 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.0 | 13.8 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.1 | 11.5 | GO:0031674 | I band(GO:0031674) |
0.6 | 11.0 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
0.8 | 10.3 | GO:0005862 | muscle thin filament tropomyosin(GO:0005862) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
7.0 | 70.4 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.5 | 27.3 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.1 | 24.8 | GO:0001227 | transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001227) |
1.2 | 18.4 | GO:0005523 | tropomyosin binding(GO:0005523) |
1.6 | 16.0 | GO:0031014 | troponin T binding(GO:0031014) |
0.2 | 12.9 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
1.3 | 12.1 | GO:0047623 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.2 | 12.0 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) |
0.3 | 11.2 | GO:0043395 | heparan sulfate proteoglycan binding(GO:0043395) |
0.4 | 11.0 | GO:0016676 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 19.3 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.2 | 14.0 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.1 | 12.0 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
0.1 | 6.8 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.3 | 6.5 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.2 | 6.4 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.1 | 6.4 | PID NOTCH PATHWAY | Notch signaling pathway |
0.2 | 5.8 | PID IGF1 PATHWAY | IGF1 pathway |
0.0 | 5.6 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.2 | 5.5 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.8 | 79.1 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
1.1 | 56.4 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.3 | 17.5 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.3 | 13.8 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.6 | 12.1 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.5 | 11.2 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.3 | 10.2 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.0 | 8.8 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
0.2 | 8.3 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
0.5 | 6.4 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |